Isolation of Tamoxifen Resistant MCF-7 Breast Cancer Cells
Author Information
Author(s): M. Toil, A.L. Harris, R. Bicknell
Primary Institution: Imperial Cancer Research Fund, Institute of Molecular Medicine, University of Oxford
Hypothesis
Can tamoxifen resistance be induced in MCF-7 breast cancer cells through cDNA transfection?
Conclusion
The study successfully isolated a tamoxifen resistant MCF-7 cell line that retains estrogen receptors and provides a model for investigating anti-estrogen resistance mechanisms.
Supporting Evidence
- Clone 9 cells were significantly more resistant to tamoxifen than wild type MCF-7 cells.
- Clone 9 retained estrogen receptors despite being resistant to tamoxifen.
- Conditioned media from clone 9 stimulated growth in both clone 9 and wild type cells.
Takeaway
Researchers created a special type of breast cancer cell that doesn't respond to a common treatment called tamoxifen, helping us understand why some patients stop responding to this medicine.
Methodology
MCF-7 cells were transfected with cDNA libraries and selected for tamoxifen resistance through a series of growth assays and xenograft studies.
Limitations
The study primarily focuses on one cell line and may not fully represent the complexity of tamoxifen resistance in all breast cancer cases.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website